Solmetex(R) Introduces NEW Sterisil(R) R2A with FASTRead(TM)
This innovation is supported by recent studies that show the majority of water samples submitted to R2A labs which fail to meet the safety standard, fail rapidly, often within the first 24 hours. "These are the 'fast failures'" said Scott Snyder, Chief Marketing Officer at Solmetex. "So instead of waiting 5-7 days, we're adding an early step and taking a "fast read" of all samples at 24 hours*. This enables us to provide early notification to the dental office if the sample already exceeds the EPA standard. This now enables offices to take corrective action immediately, days sooner than the current industry standard."
"We recognize the challenges and costs that dental practices face while waiting for results or, in some cases, having to temporarily close an operatory" said Gene Dorff, CEO at Solmetex. "As experts in dental water for over 30 years, our goal is to provide the best products and support to ensure that practices can take remedial action when necessary and continue to deliver safe and effective dental care to their patients. We feel that providing Sterisil with FASTRead, at no additional cost, is just the right thing to do."
The new Sterisil® R2A with FASTRead enables dental practices to take corrective action and get a head start on treating potentially unsafe waterlines. Practices will receive a personalized phone call with early notification and support if their sample indicates potential failure. Sterisil R2A with FASTREAD is powered by DentiSafe, Dentistry's only EPA certified Lab. "The technology and process we developed with FASTRead is a major step forward in keeping patients and staff safe from preventable infections. I'm thrilled that Solmetex and Sterisil are partnering with us to bring this innovation to dentistry." said J. Michael Puckett, DDS, Founder of DentiSafe.
For information on waterline products and support, contact Solmetex at 800-216-5505 or visit www.solmetex.com
*Early notification within 24 hours of receipt of sample. Not all test failures can be identified within 24 hours. Final test results available in 5-7 days on the My Solutions Center portal.
About Solmetex
Solmetex has been a trusted leader in dental water solutions for over 30 years, dedicated to ensuring the highest standards of water safety in dental practices. Our Solmetex®, Sterisil® and DryShield® brands provide Dentistry's only complete end-to-end solution for water safety. Our focus on patient and practice safety has made us the preferred choice for dental offices throughout North America.
Contact:
Kristina DonehewVP, MarketingSolmetex(508) 986-2337kdonehew@solmetex.comwww.solmetex.com
SOURCE: Solmetex, LLC
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
2 hours ago
- San Francisco Chronicle
EPA puts on leave 139 employees who spoke out against policies under Trump
The Environmental Protection Agency on Thursday put on administrative leave 139 employees who signed a 'declaration of dissent' with its policies, accusing them of 'unlawfully undermining' the Trump administration's agenda. In a letter made public Monday, the employees wrote that the agency is no longer living up to its mission to protect human health and the environment. The letter represented rare public criticism from agency employees who knew they could face blowback for speaking out against a weakening of funding and federal support for climate, environmental and health science. In a statement Thursday, the EPA said it has a 'zero-tolerance policy for career bureaucrats unlawfully undermining, sabotaging and undercutting' the Trump administration's agenda. Employees were notified that they had been placed in a 'temporary, non-duty, paid status' for the next two weeks, pending an 'administrative investigation,' according to a copy of the email obtained by The Associated Press. 'It is important that you understand that this is not a disciplinary action,' the email read. More than 170 EPA employees put their names to the document, with about 100 more signing anonymously out of fear of retaliation, according to Jeremy Berg, a former editor-in-chief of Science magazine who is not an EPA employee but was among non-EPA scientists or academics to also sign. Scientists at the National Institutes of Health made a similar move in June, when nearly 100 employees signed a declaration that assailed Trump administration 'policies that undermine the NIH mission, waste public resources, and harm the health of Americans and people across the globe.' An additional 250 of their colleagues endorsed the declaration without using their names. But no one at NIH has been placed on administrative leave for signing the declaration and there has been no known retribution against them, Jenna Norton, a lead organizer of the statement, told AP on Thursday. Norton oversees health disparity research at the agency's National Institute of Diabetes and Digestive and Kidney Diseases. NIH Director Jay Bhattacharya, in his confirmation hearings, had pledged openness to views that might conflict with his own, saying dissent is the 'essence of science.' Under Administrator Lee Zeldin, EPA has cut funding for environmental improvements in minority communities, vowed to roll back federal regulations that lower air pollution in national parks and tribal reservations, wants to undo a ban on a type of asbestos and proposed repealing rules that limit planet-warming greenhouse gas emissions from power plants fueled by coal and natural gas. Zeldin began reorganizing the EPA's research and development office as part of his push to slash its budget and gut its study of climate change and environmental justice. And he's seeking to roll back pollution rules that an AP examination found were estimated to save 30,000 lives and $275 billion every year. The EPA responded to the employees' letter earlier this week by saying policy decisions 'are a result of a process where Administrator Zeldin is briefed on the latest research and science by EPA's career professionals, and the vast majority who are consummate professionals who take pride in the work this agency does day in and day out.' ___
Business Upturn
3 hours ago
- Business Upturn
PhenQ Updates 2025 Formula With Strongest OTC Appetite Suppressant Profile and Clinically Studied Craving Support Ingredients
Austin, July 03, 2025 (GLOBE NEWSWIRE) — Section 1 – Introduction As public discourse around weight management increasingly centers on metabolic wellness and lifestyle sustainability, interest in ingredient transparency and multi-pronged dietary support has grown significantly. Search trends across wellness communities indicate a shift from short-term diet strategies to long-view approaches that integrate energy regulation, appetite balance, and metabolic efficiency. Consumers are more likely to seek out formulas that address more than one aspect of weight control—especially those that avoid extreme stimulant profiles or single-function targeting. This behavioral shift has coincided with broader public interest in natural compounds supported by nutritional research, such as amino acids, botanicals, and metabolism-supporting minerals. In particular, ingredients that can be framed within the context of thermogenesis, satiety, and nutritional synergy are gaining traction. As a result, consumer demand continues to evolve toward formulations that offer multi-targeted mechanisms using non-synthetic, generally recognized as safe (GRAS) compounds. In response to these developments, formulations that were once labeled 'fat burners' are being reevaluated under broader criteria—namely, how they fit into non-clinical, whole-body support frameworks without promising weight loss as a singular outcome. Brands operating in this space are adjusting messaging and formulation strategies to meet heightened scrutiny around claims, sourcing, and ingredient function transparency. For more information about PhenQ's updated formulation and full ingredient profile, visit the official website Section 2 – Product Announcement or Update PhenQ has announced an updated 2025 formulation of its non-prescription weight management system, designed to align with shifting consumer expectations for ingredient integrity and multi-mechanism nutritional support. This latest version of the product reinforces its core structure around five key wellness pathways: thermogenic activation, fat storage moderation, appetite regulation, mood support, and metabolic energy balance. The proprietary blend remains anchored by α-Lacys Reset®, a patented compound combining alpha-lipoic acid, magnesium, and cysteine base. Recent research continues to frame this ingredient as a catalyst for thermogenic activity and metabolic responsiveness, without relying on excessive stimulant content. The brand's decision to retain α-Lacys Reset® underscores a science-forward approach to addressing metabolic function using nutritionally supported compounds. Additional adjustments to the formulation include expanded concentrations of traditional metabolism-assisting agents such as Capsimax® powder, natural caffeine, and chromium picolinate. These ingredients have remained popular within weight management circles not for their standalone impact, but for their role within comprehensive nutritional strategies that prioritize satiety, energy production, and micronutrient replenishment. The updated formulation also introduces InnoSlim®, a patented blend of ginseng and astragalus, which is gaining visibility for its role in supporting glucose metabolism and carbohydrate absorption. Together with iodine, B-vitamins, and L-carnitine fumarate, these additions provide nutritional diversity intended to complement modern wellness habits without necessitating disruptive lifestyle changes. PhenQ continues to frame its positioning within the non-clinical category, emphasizing that its formulation is not a treatment protocol but rather a supportive approach to general metabolic wellness. In line with current market preferences, the updated product contains no synthetic fat-blockers, no hormonal agents, and no ingredients classified as controlled substances. It is manufactured in GMP-certified facilities in the U.S. and U.K., using raw materials that meet quality assurance and regulatory thresholds applicable to the nutritional supplement category. This update reflects PhenQ's broader effort to participate in the global transition toward transparent, non-promissory wellness solutions that emphasize functional synergy over one-dimensional outcomes. Section 3 – Consumer Trend Overview Over the past several years, consumer search behavior surrounding weight management supplements has steadily migrated toward holistic, ingredient-conscious products. This shift reflects a broader interest in addressing multiple factors influencing body composition, such as appetite cues, metabolic output, and emotional resilience during calorie-restricted phases. Data drawn from digital wellness communities, search engine queries, and public forums suggest that buyers are placing greater emphasis on transparency and ingredient credibility than on dramatic claims or isolated outcomes. As skepticism grows toward overstated weight loss advertisements, conversations have increasingly focused on understanding what individual ingredients do within the broader context of metabolism. This includes a move away from traditional fat-burning stimulants toward botanical compounds and cofactor nutrients that support the body's natural energy processes without pushing physiological extremes. One emerging theme within consumer discourse is the demand for formulas that consider long-term sustainability. For instance, users are more likely to engage with products that support thermogenesis, mood balance, and fatigue reduction as part of a lifestyle plan rather than isolated 'quick fixes.' These preferences are especially prominent among wellness-oriented audiences who value dietary autonomy, ingredient traceability, and scientific support over trend-based marketing. PhenQ's 2025 update appears aligned with these evolving expectations. The decision to highlight ingredient functionality—without centering outcomes or guarantees—places it within the emerging category of non-clinical metabolic support formulations. Rather than categorizing weight management through a purely physical lens, the updated structure acknowledges psychological and behavioral components such as cravings, motivation, and energy consistency. This trend-centric positioning avoids reliance on transactional language and instead contributes to a more nuanced public understanding of how multi-mechanism supplements may complement existing wellness routines. As more consumers seek out metabolic support rooted in credible nutrition science, the demand for well-rounded, stimulant-moderated solutions is expected to continue growing. Consumers seeking detailed ingredient sourcing, manufacturing practices, and research references may visit official website for additional information. Section 4 – Ingredient or Technology Spotlight The 2025 PhenQ formulation is structured around a series of recognizable and increasingly studied natural ingredients, each selected for its contribution to multi-pathway metabolic support. Central to the formula is α-Lacys Reset®, a patented compound combining alpha-lipoic acid (ALA), magnesium, and cysteine base. This ingredient has been examined in placebo-controlled clinical contexts for its potential to activate thermogenesis and influence body composition markers within the parameters of non-prescription supplementation. α-Lacys Reset® is joined by Capsimax® powder, a highly bioavailable form of concentrated capsaicinoids derived from chili peppers. Research surrounding this ingredient highlights its role in increasing thermogenic efficiency and metabolic expenditure, while also providing digestive tract tolerance compared to raw pepper extracts. Its use has become widespread in formulations that seek to support heat production without relying on high doses of stimulants. Another key component is chromium picolinate, a trace mineral with a long-standing presence in dietary supplements. While not associated with weight loss as a standalone agent, chromium is often cited in nutrition literature for its involvement in glucose metabolism and its reported influence on carbohydrate-related cravings. Its inclusion in PhenQ's formulation supports the product's emphasis on appetite regulation and micronutrient synergy. The updated version of PhenQ also includes InnoSlim®, a proprietary blend of Panax notoginseng and Astragalus membranaceus. Recent studies have framed this ingredient as a potential modulator of AMPK pathways and carbohydrate absorption rates. InnoSlim® is becoming a frequent addition to formulas positioned within blood sugar awareness and metabolic health categories. Additional ingredients such as nopal cactus and L-carnitine fumarate contribute to the formula's nutritional profile. Nopal, a fibrous cactus traditionally consumed in various cultures, has been associated with satiety and lipid-binding activity in digestive contexts. L-carnitine, an amino acid compound found in red meat and plant-based sources, is commonly used in nutritional protocols aimed at supporting energy metabolism and recovery. Collectively, these ingredients reflect a formulation philosophy that prioritizes synergistic activity and scientific credibility over bold outcome promises or single-compound dependence. Section 5 – User Journey Narrative / Market Reception As metabolic health continues to receive attention in digital wellness spaces, public curiosity around multi-action supplements like PhenQ has remained steady. Social media forums, community discussion threads, and independent blogs reflect an ongoing interest in products that aim to simplify the experience of managing appetite, mood, and energy — all without the complications associated with pharmaceutical interventions or overly stimulant-heavy alternatives. What distinguishes PhenQ's market positioning is its communication style, which avoids exaggerated results and instead centers around science-informed transparency. Across various digital channels, users frequently raise questions about ingredient sourcing, manufacturing integrity, and whether a given formula complements modern wellness routines — particularly for those pursuing health improvements without restrictive diet regimens or clinical oversight. The company's updated formulation and messaging strategy appear to resonate with these inquiries. Rather than promoting a singular path to weight loss, the updated formula is structured to reflect broader consumer themes, including the desire for satiety support, energy normalization, and formulation diversity. The addition of ingredients such as InnoSlim® and B-vitamins addresses increasing demand for micronutrient optimization and support for metabolic pathways often disrupted by caloric deficit or lifestyle changes. In discussions around natural supplements, audiences increasingly prioritize how a product fits into a larger picture of emotional consistency and sustainable energy, especially in contrast to 'quick burn' formulations that rely heavily on caffeine or unverified compounds. The fact that PhenQ includes commonly understood ingredients like L-carnitine, magnesium, and caffeine — but in modulated, complementary concentrations — contributes to its positioning as an integrative rather than transformative option. This framing, combined with a formula that does not require a prescription and is manufactured under GMP conditions, continues to support its relevance among consumers seeking nutritional autonomy. Rather than emphasizing a transactional promise of transformation, PhenQ appears to contribute to a more moderate and sustainable public dialogue on wellness supplements that support—rather than replace—healthy lifestyle practices. Interested individuals can find formulation disclosures and regulatory information via PhenQ's official website. Section 6 – Availability and Transparency Statement PhenQ's updated formulation is available through its official platform, where consumers can review detailed ingredient information, third-party sourcing disclosures, and manufacturing standards. The product is manufactured in facilities that meet current Good Manufacturing Practice (cGMP) certification standards in both the United States and United Kingdom, with raw ingredients selected according to internal quality assurance protocols. As part of its transparency commitment, PhenQ provides accessible documentation for its trademarked compounds such as α-Lacys Reset® and InnoSlim®, along with references to publicly available nutritional research supporting the inclusion of individual ingredients. The company emphasizes that its supplement is intended for informational and lifestyle-support purposes only and does not position the product as a treatment or replacement for medical supervision. Individuals interested in metabolic wellness strategies are encouraged to explore educational materials hosted on the PhenQ site, which outline general formulation philosophy, frequently asked questions, and links to peer-reviewed research. No prescription is required for purchase, and the product is available exclusively through the company's designated online retail channels. Section 7 – Final Observations & Industry Context The 2025 update of PhenQ arrives at a time when the supplement industry is undergoing renewed scrutiny and transformation, particularly within the weight management category. As consumer expectations shift from single-purpose diet products to multi-functional wellness solutions, brands are reassessing both how they formulate products and how they communicate ingredient purpose. This evolution marks a broader move away from direct weight loss promises toward formulations that acknowledge the interconnected nature of energy, appetite, and motivation. Across the wellness landscape, ingredients once considered niche—such as alpha-lipoic acid, nopal cactus, and botanical extracts like astragalus—are gaining mainstream attention. The increasing presence of these compounds in consumer conversations suggests a growing interest in plant-based and functional ingredient science, especially when backed by human trials and documented safety profiles. PhenQ's approach reflects a maturing sector that recognizes the importance of transparency, nuanced messaging, and sustainable lifestyle support. Rather than offering a singular solution, the formulation aims to complement a growing range of consumer wellness behaviors, including mindful eating, energy balancing, and non-clinical supplementation. As demand for transparency and scientific literacy rises, the presence of products structured like PhenQ—multi-pathway, non-prescription, and disclosure-focused—signals the industry's broader direction. This includes higher consumer literacy, diversified expectations, and an evolving standard of what constitutes a trustworthy supplement. Section 8 – Public Commentary Theme Summary Public discussions surrounding PhenQ's formulation have generated a range of observations reflecting both interest and critical inquiry. A recurring theme across digital wellness communities is the product's emphasis on combining multiple known ingredients into a single formula, which some individuals view as a time-saving approach to general metabolic support. Others have noted the appeal of stimulant moderation—citing the inclusion of moderate levels of caffeine and an absence of harsher synthetic additives—as aligned with preferences for less disruptive daily routines. Among individuals actively comparing non-prescription supplements, the presence of clinically referenced ingredients such as α-Lacys Reset® and chromium picolinate has been identified as a point of interest. These components, frequently mentioned in scientific literature for their roles in energy metabolism and appetite regulation, are often viewed as more familiar or trusted compared to newer or lesser-known compounds. Conversely, some users have raised questions about the realistic scope of results when using non-clinical supplements. There is ongoing discourse around the limitations of over-the-counter solutions, with particular attention paid to the importance of maintaining lifestyle consistency, including diet and physical activity. This reflects a broader caution in the wellness space—an understanding that no standalone product can substitute for foundational health behaviors. Additionally, public commentary has reflected a desire for more transparent sourcing data, third-party testing disclosures, and clearer long-term usage guidelines. These requests are in line with increasing consumer expectations for traceability and safety, especially in products used over extended periods. Overall, discussion themes suggest that PhenQ is being evaluated primarily for its formulation logic, ingredient familiarity, and alignment with wellness-focused—not outcome-promising—weight management strategies. About PhenQ PhenQ is a U.S.- and U.K.-based wellness brand specializing in non-prescription formulations designed to support metabolic health through ingredient transparency and multi-mechanism nutritional design. Since its initial launch, PhenQ has developed a science-informed product portfolio focused on integrating botanical extracts, essential minerals, and amino acid complexes into accessible, non-clinical supplements. The company's mission centers on empowering individuals to make informed wellness decisions through evidence-aligned formulation and educational transparency. PhenQ does not provide medical treatment or diagnostic services. Its products are not intended to diagnose, treat, cure, or prevent any disease, and should be used only as part of a broader wellness routine that includes professional healthcare consultation where appropriate. Contact: Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
The Hill
5 hours ago
- The Hill
House OKs megabill, includes green tax credit cuts
The Big Story The House approved the Senate's version of the Republican policy bill, sending major cuts to climate-friendly tax credits to Trump's desk. © Greg Nash The legislation passed the House 218-214, with Reps. Thomas Massie (Ky.) and Brian Fitzpatrick (Pa.), voting with Democrats against the measure. The overwhelming Republican support was a reflection of both the enormous appetite within the GOP for extending the 2017 tax cuts and a demonstration of Trump's immense grip on his party, where loyalty to the president is presumed and defectors risk a career-ending political backlash. A major piece of the bill is its cuts to tax credits for renewable energy and electric vehicles. The EV credit disappears after Sept. 30. Meanwhile, renewables either have to start construction in the next year or produce electricity by 2028 to have access to the credit. The latter cuts have been a major point of contention in deliberations thus far, with moderates saying it goes too far and conservatives saying it didn't go far enough. Ultimately, the vast majority of swing district Republicans and Freedom Caucusers alike voted for the legislation. Read more here, from The Hill's Mike Lillis, Mychael Schnell and Emily Brooks. Programming note: There will be no newsletter tomorrow for the 4th of July! We'll be back on Monday. Welcome to The Hill's Energy & Environment newsletter, I'm Rachel Frazin — keeping you up to speed on the policies impacting everything from oil and gas to new supply chains. Programming note: This newsletter will not publish tomorrow for the July 4 holiday. See you Monday! Did someone forward you this newsletter? Subscribe here. Essential Reads How policy will affect the energy and environment sectors now and in the future: EPA places staffers who signed 'dissent' letter on leave The Environmental Protection Agency (EPA) is placing staffers who signed a letter of dissent against the Trump administration's actions and policies on leave. GOP megabill extends and expands compensation for nuclear weapons radiation victims The Republican megabill passed by Congress on Thursday contains an extension and expansion of a program to compensate Americans who developed cancer from radiation exposure linked to the U.S. nuclear weapons program. Inside Trump's push to pass the 'big, beautiful bill' With the signature policy bill of President Trump's second term hanging in the balance this week, the president and his allies got to work, using a mixture of vinegar and honey to win over skeptics and ensure its final passage. What We're Reading News we've flagged from other outlets touching on energy issues, the environment and other topics: 'Even if we stop drinking we will be exposed': Parts of France have banned tap water. Is it a warning for the rest of Europe? (The Guardian) On Our Radar Upcoming news themes and events we're watching: Wednesday Thursday What Others are Reading Two key stories on The Hill right now: House sends GOP's 'big, beautiful bill' to Trump's desk in major win for Republicans The 'big, beautiful bill' is heading to President Trump's desk. Read more How your taxes will change after Trump signs the 'big, beautiful bill' into law With the GOP's 'big, beautiful bill' headed to President Trump's desk for signature Friday, wealthy Americans are poised to receive significant tax breaks partly offset by steep cuts to social welfare programs. Read more You're all caught up. See you Monday! Thank you for signing up! Subscribe to more newsletters here
